GENESIS Tech Transfer Boost invests €25,000 in the biotech company Spinally Medical ... 07 June, 2023
The spin-off RetinaReadRisk has been created for marketing software and a mobile system based on artificial intelligence to detect diabetic retinopathy in the early stages ... 21 March, 2023
GENESIS Biomed receives the award for the best biomedical consultancy in the XI Edition of the National Awards El Suplemento ... 21 June, 2022
GENESIS Biomed and FI Group create GENESIS Tech Transfer Boost, a new investment vehicle that will invest in early stage projects from healthcare research ... 26 April, 2022
The Universidad Autónoma de Madrid launches a specific entrepreneurship programme for health researchers in collaboration with GENESIS Biomed ... 06 April, 2022
The European EIT Health-supported project Retina-Read-Risk will detect diabetic retinopathy through telemedicine ... 14 March, 2022
